Medicament for treating anxiety disorder

An anxiety disorder and pharmaceutical technology, applied in the field of medicine, can solve problems such as adverse reactions, drug dependence, slow onset of effect, etc., and achieve good safety and clear curative effect

Inactive Publication Date: 2013-06-12
张勇
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine currently mainly uses drug intervention for the treatment of this disease, but the existing drugs have many problems such as dependence, slow onset of effect, adverse reactions, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0012] Clinical data There are 60 cases in this group, including 30 males and 30 females; aged 22 to 48 years, with an average of 33 years old. The diagnostic criteria refer to the diagnostic criteria of CCMD-3 anxiety disorder (Psychiatric Branch of Chinese Medical Association. Chinese Mental Disorders Classification and Diagnostic Criteria [M] 3rd Edition. Jinan: Shandong Science and Technology Press 2001: 103). , stagnation of liver qi, worry and worry, spleen dysfunction.

[0013] Use the decoction prepared in the embodiment for treatment, 2 times a day, each oral administration of 50 milliliters. 2 months of treatment is a course of treatment.

[0014] Efficacy criteria were evaluated according to the diagnostic efficacy criteria of TCM syndromes revised in 1991 by the Professional Committee of Mental Diseases, China Association of Integrative Traditional Chinese and Western Medicine. Healed: Symptoms disappear, mood is normal; Improvement: Symptoms are relieved, and mo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating anxiety disorder. The medicament is prepared from the following substances in parts by weight of 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of seed of cowherb, 1-15 parts of peach kernel, 10-20 parts of radices sileris, 15-30 parts of oriental wormwood, 20-30 parts of fructus terminaliae billericae, 10-20 parts of scutellaria baicalensis, 1-20 parts of celandine, 10-25 parts of folium mori, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-20 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of root of kudzu vine, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of chinese lantern-plant, 15-25 parts of root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All components of the medicament for treating the anxiety disorder disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating anxiety. Background technique [0002] Anxiety disorder, also known as anxiety neurosis, is an emotional disorder characterized by persistent nervousness, worry, fear or paroxysmal panic, accompanied by behavioral characteristics such as autonomic nervous system symptoms and restlessness in movement. Anxiety or fear expressed by patients with anxiety disorders is often insubstantial or inconsistent with the real situation. Western medicine currently mainly uses drug intervention for the treatment of this disease, but the existing drugs have many problems such as dependence, slow onset of effect, and adverse reactions. Contents of the invention [0003] The object of the present invention is to provide a medicament for treating anxiety. [0004] In order to realize the object of the present invention, the present invention provides a kind of medicament for tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P25/22
Inventor 徐道慧
Owner 张勇
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products